Molecular Partners AG -ADRMOLN
13F holders, Q2 2026 (June 30)5holders +1
2new positions
1sold out
1famous investor
$3.84avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Molecular Partners AG -ADR (MOLN) in their 13F filings, up 1 from Q1 2026. 2 opened new positions and 1 sold out. The largest holders were Montanova Capital, LLC ($8.6M), BVF Inc. ($5.1M) and Citadel Advisors ($65K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Molecular Partners AG -ADR
- CUSIP
- 60853G106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $66K |
| Exits | 1 | $62K |
All 13F filers, Q1 2026 → Q2 2026: 17,458 shares bought and 15,543 shares sold, net +1,915 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Montanova Capital, LLC | 0.18% | No change | 2,221,494 | $8.6M |
| BVF Inc. | 0.13% | No change | 1,353,968 | $5.1M |
| Citadel Advisors | 0.00% | New | 17,179 | $65K |
| Morgan Stanley | 0.00% | No change | 367 | $1K |
| UBS Group AG | 0.00% | New | 279 | $1K |
"% of holder's portfolio" is MOLN's weight in each manager's 13F, not the share of Molecular Partners AG -ADR the manager owns.